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The human POLG gene encodes the catalytic subunit of mitochondrial DNA polymerase g (pol g). Mutations
in pol g are associated with a spectrum of disease phenotypes including autosomal dominant and recessive
forms of progressive external ophthalmoplegia, spino-cerebellar ataxia and epilepsy, and Alpers–
Huttenlocher hepatocerebral poliodystrophy. Multiple deletions, or depletion of mtDNA in affected tissues,
are the molecular hallmarks of pol g mutations. To shed light on the pathogenic mechanisms leading to
these phenotypes, we have introduced in MIP1, the yeast homologue of POLG, two mutations equivalent
to the human Y955C and G268A mutations, which are associated with dominant and recessive PEO, respect-
ively. Both mutations induced the generation of petite colonies, carrying either rearranged (r2) or no (r0)
mtDNA. Mutations in genes that control the mitochondrial supply of deoxynucleotides (dNTP) affect the
mtDNA integrity in both humans and yeast. To test whether the manipulation of the dNTP pool can modify
the effects of pol g mutations in yeast, we have overexpressed a dNTP checkpoint enzyme, ribonucleotide
reductase, RNR1, or deleted its inhibitor, SML1. In both mutant strains, the petite mutability was dramatically
reduced. The same result was obtained by exposing the mutant strains to dihydrolipoic acid, an anti-oxidant
agent. Therefore, an increase of the mitochondrial dNTP pool and/or a decrease of reactive oxygen species
can prevent the mtDNA damage induced by pol g mutations in yeast and, possibly, in humans.
INTRODUCTION
Different mutations in POLG, the gene encording the catalytic
subunit of the mitochondrial DNA polymerase (polymerase
gamma, pol g) (1) are associated with a spectrum of
human mitochondrial disorders, including autosomal domi-
nant (ad) and autosomal recessive (ar) progressive external
ophthalmoplegia (PEO), juvenile spino-cerebellar ataxia and
epilepsy (2) and infantile hepatopatic poliodystrophy, or
Alpers–Huttenlocher syndrome (AHS) (3). Adult-onset
adPEO and arPEO syndromes are characterized by the
accumulation of multiple mtDNA deletions in affected
tissues (4), whereas the most severe syndrome, AHS, shows
marked reduction in the mtDNA copy number in liver (5)
and, possibly, brain. Beside mutations in POLG, adPEO can
also be caused by heterozygous mutations in ANT1, encoding
the ADP/ATP translocator (6), and TWINKLE, encoding a
mitochondrial helicase (7). ANT1 and POLG genes,
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but not TWINKLE, are highly conserved from humans to the
facultative budding yeast Saccharomyces cerevisiae: the yeast
AAC2 gene corresponds to ANT1 (8), whereas MIP1 co-
rresponds to POLG (9). This makes it possible to
introduce and study in AAC2 and MIP1 the mutations
that are equivalent to those affecting mtDNA stability in
humans (10–12).
Human pol g is composed of a 140 kDa catalytic subunit
A and a 55 kDa accessory subunit B, which increases the
processivity of mtDNA synthesis. Pol gA comprises a
polymerase domain and an exonuclease proofreading
domain, separated by a linker region of 482 amino acids.
Over 60 PEO-associated mutations have been found in
POLG (13,14). Most of the dominant POLG mutations
are in the polymerase domain, whereas most of the
recessive mutations are in the exonuclease or in the
spacer domains. Only one mutation has been found in
pol gB (14).
In the present work, we have introduced in MIP1 two
mutations that are equivalent to two pathogenic mutations
in pol gA, the Y955C and the G268A. The first mutation is
associated with adPEO (1), and the second is associated
with arPEO (15). We have demonstrated that the equivalent
yeast mutations behave as dominant and recessive traits,
respectively, and, by inducing severe damage to, or the
loss of mtDNA, determined an increase of either r2 or r0
petite colonies. We have also shown that the yeast phenotype
can be suppressed by increasing the mitochondrial dNTP pool,
through the overexpression of RNR1, encoding the ribo-
nucleotide reductase (RNR1) (16,17), or the deletion of its
inhibitor, SML1 (18,19). Finally, we have studied the
effect of a reactive oxygen species (ROS) scavenger on our
mutants. Our results indicate that ROS damage contributes
to mtDNA instability in yeast.
RESULTS
Effect of MIP1 alleles equivalent to PEO-associated
hPOLG mutants on oxidative growth phenotype
Phenotypic analysis showed that the haploid mip1Y757C
mutant strain (Dmip1//mip1Y757C) was unable to grow on 2%
ethanol, indicating the absence of respiration. As exemplified
by the experiment shown in Figure 1, the spectrum profile of
mitochondria isolated from this strain consistently lacked
the peaks specific to cytochromes b and aa3, which are part
of the mtDNA-dependent complexes III and IV of the
respiratory chain, whereas the peak specific to cytochrome c,
a nucleus-encoded protein, was normal. Contrariwise, the
haploid mip1G224A mutant strain (Dmip1//mip1G224A) was
able to grow on ethanol, displayed a normal cytochrome
profile (Fig. 1) and retained a normal respiratory activity (data
not shown). The MIP1/Dmip1 heterozygous diploid strain, car-
rying either the mip1Y757C or the mip1G224A mutant alleles
(MIP1/Dmip1//mip1Y757C and MIP1/Dmip1//mip1G224A) both
failed to show a significant growth defect; the cytochrome
profile and respiration were normal in both strains.
Determination of petite frequency and evaluation
of the nature of the petite mutations
In humans, both G268A and Y955C mutations induce the
accumulation of multiple deletions of mtDNA. In S. cerevisiae,
deletions of mtDNA are known as petite mutations.
Conditions that increase mtDNA mutability also increase the
frequency of petites (20). In order to evaluate whether an
effect similar to that observed in humans was produced by
the equivalent mutations in yeast, we measured the frequency
of petite mutants in haploid Dmip1 strains carrying either
the mip1G224A or the mip1Y757C mutant allele. The results
reported in Figure 2 indicate that, in the mip1Y757C haploid
strain, the petite frequency was 100%, as previously described
(12). In the mip1G224A haploid strain, the petite frequency was
~2.5-fold the frequency determined in Dmip1 haploid strains
transformed with the MIP1 wild-type allele.
In the MIP1/Dmip1 diploid strain carrying the mip1G224A
mutant alleles, the petite frequency was equivalent to that
of the background level observed in the same diploid
strain carrying the MIP1 allele. This result indicates that
mip1G224A behaves as a recessive allele in yeast, like the cor-
responding G268A mutation does in humans. In the same
strain carrying the mip1Y757C mutant allele, the petite
frequency was ~21-fold, indicating that the mutation is domi-
nant in yeast, as it is in humans.
Petite mutants can be either r2 (that is, cells in which the
mtDNA is partially deleted) or r0 (that is, cells in which the
mtDNA is completely lost). When r2 mutants are crossed
with a mit2 mutant carrying a point mutation, rþ cells are
produced by recombination, provided that the mit2 point
mutation maps in a region conserved in the r2 mtDNA.
Contrariwise, r0 mutants, which are completely devoid of
Figure 1. Oxidized versus reduced cytochrome spectra of the Dmip1 strain
(DWM-5A), transformed with wt MIP1, pFL39 plasmid (no insert),
mip1G224A and mip1Y757C mutant alleles cloned in pFL39. The peaks at 550,
560 and 602 nm (vertical bars) correspond to cytochromes c, b and aa3,
respectively. The height of each peak relative to the baseline of each spectrum
is an index of cytochrome content.
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mtDNA, are unable to produce rþ cells. In order to evaluate
the nature of the petite colonies produced by our
mutant strains, we crossed 200 petite clones from the
Dmip1//MIP1 strain and 200 petite clones from Dmip1//
mip1G224A with four mit2 mutants. Each mit2 mutant harbours
a different deleterious point mutation, namely, in the first and
sixth exons of the cob gene, in the cox2 gene and in the cox3
gene (see Methods). The diploid clones resulting from the
crosses were tested for their ability to grow on glycerol.
Approximately 56% of the Dmip1//MIP1 and 54% of the
Dmip1//mip1G224A petite clones were able to complement at
least one of the mit2 mutations, indicating that these clones
were r2 (Table 1). None of the clones derived from the
Dmip1//mipY757C strain was able to complement any of the
mit2 mutations, indicating that they were r0. This was consist-
ently confirmed by Southern-blot analysis, as exemplified in
Figure 3 (see also Methods).
The complementation test cannot be used to evaluate the
nature of the petite mutants in wt/mutant diploid strains. To
mimic the diploid condition, we have constructed heteroallelic
strains by introducing the wt MIP1 or the mutated mip1Y757C
alleles in the haploid wt strain W303-1B. We first established
that the heteroallelic MIP1//mip1Y757C and the homoallelic
MIP1//MIP1 strains produced petite colonies with a frequency
similar to that observed in diploid strains carrying the corres-
ponding mip1Y757C and MIP1 alleles (data not shown). The
transformants were then crossed with the mit2 testers.
Approximately 74% of 200 MIP1//MIP1 homoallelic petite
clones was able to complement each of the mit2 mutations
but only 49% of 500 heteroallelic MIP1//mip1Y757C petite
clones was able to do so, again indicating that the Y757C
mutation induces the loss of mtDNA (Table 1).
Determination of mtDNA point mutations
We next analysed whether our mip1 mutations increased the
mtDNA point mutagenesis, as demonstrated by an increase
in the frequency of erythromycin-resistant (EryR) mutants.
Resistance to the drug erythromycin in yeast is acquired
through specific point mutations in the mtDNA-encoded
rRNA genes and therefore is a convenient, direct measurement
of mtDNA point mutagenesis in vivo (21). Using this assay,
we have measured mtDNA mutation frequencies in the
haploid strain Dmip1//mip1G224A and in the diploid strains
MIP1/Dmip1//mip1G224A and MIP1/Dmip1//mip1Y757C. Both
mip1G224A in haploid, and mip1Y757C in diploid conditions
showed a 10-fold and a 20-fold increase, respectively, in
mtDNA point mutagenesis, compared with that observed in
the wild-type strain. However, the MIP1/mip1G224A heterozy-
gous diploid strain failed to show any increase of EryR mutant
frequency (Table 2), again indicating that this mutation
behaves as a recessive trait also for this phenotype.
Effect of increasing dNTP pool on mitochondrial
mutability
We next tested whether an increase in the level of the dNTP
pool could rescue the mitochondrial mutability observed in
the presence of the two pathological mip1 mutations. The
increase of the dNTP pool was obtained either by overexpres-
sing the RNR1 gene, which encodes the large subunit of the
Figure 2. Determination of petite frequency in (A) haploid Dmip1 strain
transformed with wt MIP1, pFL39 plasmid without insert, mip1G224A
and mip1Y757C mutant alleles cloned in pFL39; (B) heterozygous diploid
MIP1/Dmip1 transformed with wt MIP1, pFL38 plasmid without insert,
mip1G224A and mip1Y757C mutant alleles cloned in pFL38. More than 4000
colonies/strain were scored. All values are means of three independent exper-
iments. In no case, the variation was higher than 15%. RD, respiratory
deficient cells; RS, respiratory sufficient cells.
Table 1. Percentage of petite (r0 þ r2) and percentage of r0 mutants produced
in different genetic backgrounds
Relevant genotype wt RNR1 Dsml1
% petites % r0 % petites % r0 % petites % r0
Haploid strains
Dmip1//MIP1 9 4 1.9 0.6 1.8 0.9
Dmip1//
mip1G224A
21 10 3.2 1.1 3.9 1.3
Heteroallelic
strains
MIP1//MIP1 1.5 0.4 0.5 0.1 0.5 0.1
MIP1//
mip1Y757C
32 16 9.3 3.2 4.5 1.3
Petite frequencies were defined as the percentage of colonies showing the
petite phenotype after 5 days incubation at 288C. More than 4000 colo-
nies/strains were scored. All values are means of three independent
experiments. In no case the variation was higher than 15%. r0 frequencies
were calculated as the percentage of clones unable to complement any of
mit2 mutants tested.
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ribonucleotide reductase (22) or by deleting the SML1 gene,
which encodes an inhibitor of the latter activity (18).
We transformed haploid and diploid strains harbouring the
mip1G224A or the mip1Y757C alleles with a multicopy plasmid
carrying the RNR1 gene (plasmid pWJ841). We also
constructed a haploid Dsml1, Dmip1 strain and a diploid
Dsml1/Dsml1 MIP1/Dmip1 strain, which were transformed
with either one of three different plasmids: the first plasmid
carried the wt MIP1 allele, the second the mip1G224A
allele and the third the mip1Y757C allele. The results reported
in Figure 4 indicate that both conditions caused dramatic
decreases of the petite frequencies in the mutant strains. The
petite mutability was reduced approximately to the same
extent, suggesting that the protective effect on mtDNA is
likely due to the increase of the dNTP pool and not to an
unrelated effect of the RNR1 overexpression or of the SML1
deletion.
Decreased petite mutability was associated with decreased
r0 frequency (Table 1). In the presence of RNR1 overexpres-
sion, the proportion of haploid Dmip1//MIP1 r0 clones was
reduced from 46 to 33% and in the presence of the SML1 del-
etion was reduced to 28%. Similar results were obtained in the
haploid Dmip1//mip1G224A strain. The heteroallelic strain,
MIP1//mip1Y757C showed a reduction of r0 clones from 51
to 35% in the presence of overexpressed RNR1 and to 29%
in the presence of Dsml1, whereas no reduction was observed
in the MIP1//MIP1 homoallelic strain. The 4–5-fold decrease
of petite mutability and the 7–10-fold decrease of r0 fre-
quency suggest that the increase of the dNTP pool contributed
to maintain mtDNA integrity and stability.
Since the effects obtained by RNR1 overexpression were
similar to those obtained with SML1 deletion, we evaluated
the effect on mtDNA point mutability only in the Dsml1 back-
ground. The number of EryR mutants was unchanged in the
presence of the mip1G224A mutation, but decreased by
~2-fold in the presence of the mip1Y757C mutation (Table 2).
Role of ROS in mtDNA mutability
Increased production of ROS is associated with an increase in
the accumulation of mtDNA rearrangements (23,24). To
address this issue in our system, we analysed the effect of
the ROS scavenger dihydrolipoic acid on the petite mutability
of the heterozygous MIP1/Dmip1 diploid strain carrying the
mip1Y757C allele, as well as of the Dmip1 haploid strain
carrying the mip1G224A allele. Exposure to dihydrolipoic
acid decreased significantly the petite mutability in both
cases by a factor of six to eight. A clear, albeit less prominent,
effect was also observed in the mip1 and MIP1/mip1 strains
carrying the wild-type MIP1 allele (Fig. 5).
DISCUSSION
The human Y955C pol g mutation is located in the polymerase
domain. Its fidelity is 42-fold decreased in an exonuclease-
deficient background and 2-fold decreased in an exonuclease-
proficient background (25); its polymerase activity is
3000-fold decreased (26). The yeast mutation mip1Y757C, cor-
responding to Y955C, behaved like the mip1 null mutation
when introduced into a Dmip1 haploid strain. It induced a dra-
matic loss of mitochondrial DNA, as shown by the production
of 100% petite mutants that were all r0, that is, mtDNA-less
cells. In a MIP1/mip1 heterozygous diploid strain, the
Table 2. Frequency of EryR mutants
Relevant genotype wt Dsml1
Haploid strains
Dmip1//MIP1 1.1  1028 1.2  1028
Dmip1//mip1G224A 9.8  1028 11.5  1028
Diploid strains
MIP1/Dmip1//MIP1 1.0  1028 0.9  1028
MIP1/Dmip1//pFL38 3.2  1028 3.5  1028
MIP1/Dmip1//mip1Y757C 11.4  1028 5.6  1028
MIP1/Dmip1//mip1G224A 1.1  1028 1.1  1028
The frequency of erythromycin resistant mutants was calculated as
number of EryR colonies/total number of colonies, as described in
Materials and Methods.
Figure 3. Southern-blot analysis of mtDNA isolated from petite clones unable to complement any of the mit2 mutants tested (lanes 1–10). mtDNA was prepared
and analysed as described in Materials and Methods from cells grown on YNB medium supplemented with 2% glucose. mtDNA (1 mg) was digested with
EcoRV and hybridized with an mtDNA-specific probe. Lane 7 corresponds to an mtDNA-rearranged r2 clone; lanes 1–6 and 8–10 correspond to mtDNA-less
r0 clones. The mtDNA hybridization pattern of a respiratory sufficient rþ strain is shown as a normal control; examples of abnormal hybridization patterns were
obtained from a respiratory-deficient mtDNA-less r0 strain, and from two respiratory-deficient, mtDNA-rearranged r2 strains.
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mip1Y757C mutation caused a 20-fold increase in petite mut-
ability compared with the MIP1 wt allele and a 4-fold increase
compared to the mip1 null allele. The mip1Y757C mutation
caused also an increase of point mutability of mtDNA, leading
to a 10-fold increase of EryR mutations compared with the
MIP1 wt allele and a 3-fold increase compared with the
Dmip1 null allele. These results indicate that the mip1Y757C
behaves as a dominant allele, since its presence is more
deleterious to mtDNA than the absence of the MIP1 gene itself.
This behaviour mimics exactly what is observed in humans.
The human G268A is a missense mutation in the
proofreading exonuclease domain of pol gA. In homozygous
conditions, the human G268A mutation causes the accumu-
lation of both mtDNA deletions and point mutations (27). We
have observed reduced fidelity of the homologous mutation
also in yeast, where the equivalent mip1G224A allele was associ-
ated with a 2.5-fold increase in the frequency of petite clones
and a 10-fold increase in the point mutability of mtDNA.
Therefore, the phenotype is recessive in yeast as it is in humans.
The recessive phenotype is formally indicative of a
complementation exerted by the wild-type allele and is poss-
ibly due to the ability of the wild-type MIP1 polymerase to
proofread errors introduced by the mutant polymerase.
Mutations in genes that control the mitochondrial supply of
deoxynucleotides (dNTP) affect the mtDNA integrity in both
humans (28) and yeast (29).
The level of dNTP pools is under an evolutionary conserved
surveillance system that maintains genomic stability. One
important checkpoint of this control system is the RNR1. In
yeast, mutations in RNR1 increase petite mutations (30).
In both yeast and humans, the transcription of RNR1 is
induced after DNA damage. In addition, the yeast
mtDNA-damage-checkpoint proteins also regulate the RNR1
inhibitor Sml1p. After DNA damage or at S phase, the
MEC1 and RAD53 gene products control the phosphorylation
and the subsequent degradation of the Sml1 protein (31).
This control contributes to increase the synthesis of dNTPs,
necessary for DNA replication and repair. Overexpression of
RNR1 (32) or deletion of SML1 (18), both are able to rescue
the petite-inducing phenotype of a specific point mutation in
yeast pol g (mip1-1).
Figure 4. Determination of petite frequency in the presence of RNR1 overex-
pression and SML1 deletion. Relevant genotypes of different strains are indi-
cated on top of the bars. Bars indicate transformants with MIP1 or different
mip1 mutant alleles, as indicated. (A) Haploid strains transformed with wt
MIP1 and mip1G224A mutant allele cloned in pFL39; (B) diploid transformed
with wt MIP1, pFL38 plasmid without insert, mip1G224A and mip1Y757C mutant
alleles cloned in pFL38. More than 4000 colonies/strains were scored. All
values are means of three independent experiments. In no case the variation
was higher than 15%.
Figure 5. Determination of petite frequency in the presence/absence of 30 mM
dihydrolipoic acid (A) haploid Dmip1 strain transformed with wt MIP1 and
mip1G224A mutant allele cloned in pFL39; (B) heterozygous diploid MIP1/
Dmip1 transformed with wt MIP1, pFL38 plasmid without insert, mip1G224A
and mip1Y757C mutant alleles cloned in pFL38. More than 4000 colonies/
strains were scored. All values are means of three independent experiments.
In no case the variation was higher than 15%. 2L, cells untreated with
dihydrolipoic acid; þL, cells treated with dihydrolipoic acid.
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Here we show that either RNR1 overexpression or SML1
deletion, two conditions that increase the dNTP pools of the
cell, including the mitochondrial pool (19), induced a
4–8-fold reduction in the production of petite colonies of
our recombinant mutant strains. However, neither RNR1 over-
expression nor SML1 deletion decreased the frequency of EryR
clones, which is an index of the propensity of mtDNA to
accumulate point mutations. This result is similar to previous
data (33) and indicates that induction of large-scale rearrange-
ments, rather than increased point mutagenesis, is responsible
for the petite mutability induced by the two mip mutations
considered in our work. The human Y955C mutation displays
a 45-fold reduction in affinity for the incoming nucleotide
(25). Reduced affinity could determine a stalling on homopo-
lymeric runs due to frequent reiteration of a single nucleotide.
This could result in local depletion of that nucleotide and
make it difficult for a defective polymerase to incorporate
the subsequent nucleotide (34). By preventing pol g stalling,
an increase of the dNTP pool could decrease the generation
of mtDNA rearrangements, and thereby reduce the number
of petite clones. However, the increase of the dNTP pool
could also induce the rescue of petites by improving the effi-
ciency of mtDNA repair, especially in the presence of the
D268A mutation, which is an error-prone mutation, being con-
tained in the proofreading domain of pol gA. The existence of
mtDNA repair is supported by the recent demonstration that
mitochondria share several repair systems with the nucleus,
in both yeast (35) and humans (36).
MtDNA is attached to the mitochondrial inner membrane in
close proximity to the respiratory chain. Mitochondrial respiration
is a major source of ROS, which makes mtDNA vulnerable to oxi-
dative damage (23). The latter effect can lead to the production of
more ROS by impairing the electron transport chain (37), which
can in turn determine further mtDNA damage (38,39).
To evaluate whether the mitochondrial mutability conse-
quent to POLG mutations could result from ROS damage on
mtDNA, we analysed the effect of a ROS scavenger, dihydro-
lipoic acid. Exposure to dihydrolipoic acid caused a 6-fold
decrease in the petite mutability of the heterozygous MIP1/
mip1 diploid carrying the mip1Y757C dominant allele and of
the Dmip1 haploid strain carrying the mip1G224A recessive
allele. However, we could not establish whether the polymer-
ase mutations increase the amount of ROS or whether they
make the mtDNA more sensitive to ROS.
We have previously reported that the presence of ROS scaven-
gers reduced significantly the consequences of a mutation equival-
ent to an arPEO mutation in the human ANT1 gene (11). Likewise,
the data presented in this paper ushers in the development of a
rational anti-ROS strategy for patients with pol gA mutations.
MATERIALS AND METHODS
Yeast strains and media
Yeast strains are listed in Table 3. YP medium contained 1%
Bacto-yeast extract and 2% Bacto-peptone (Difco). Minimal
medium (YNB) contained 7 g/l yeast nitrogen base without
amino acids (Difco) supplemented with appropriate amino acids
and bases for auxotrophy. Various carbon sources were added at
the indicated concentrations. N1 medium contained 1%
peptone, 1% yeast extract, 2% ethanol in 50 mM phosphate
buffer at pH 6.3, supplemented with 4 g/l erythromycin (SIGMA).
Construction of yeast strains carrying mip1 mutations
Saccharomyces cerevisiae strain W303-1B (40) was used for
the construction of a null Dmip1 mutant by one step gene dis-
ruption using KanMX expression cassette (41). MIP1 ORF
was completely deleted and substituted by the Kanr marker,
whose correct target of at MIP1 locus was verified by PCR.
Oligonucleotides used for MIP1 disruption and verification
are listed in Table 3. Dmip1 mutant strain (strain OF1), r0,
was then crossed with the isogenic strain W303-1A (40),
giving rise to the diploid DWM MIP1/Dmip1 rþ. This strain
was transformed with wt MIP1 or mip1Y757C or mip1G224A
mutant alleles, cloned in the centromeric vector pFL38 or
with the empty plasmid. Diploid clones obtained will be
named: MIP1/Dmip1//MIP1, MIP1/Dmip1//mip1Y757C, MIP1/
Dmip1//mip1G224A, MIP1/Dmip1//pFL38, respectively.
Absence of MIP1 determines the complete and irreversible
loss of mtDNA. For this reason, we maintained wt MIP1
expressed by a plasmid during the construction of the
haploid mutant strains and eliminated it by plasmid shuffling
once the mutant allele was already into the cell. For the con-
struction of haploid strains, DWM strain transformed with the
pFL38MIP1 plasmid was sporulated. By tetrad analysis
the haploid spore DWM-5A, carrying the Dmip1 disruption
and the pFL38MIP1, and therefore rþ, was selected. This strain
was the host for wt MIP1 or mip1Y757C or mip1G224A mutant
allele, cloned in the pFL39 centromeric vector. By plasmid shuf-
fling in the presence of 5-fluoro orotic acid (5FOA, SIGMA), it
was then possible to isolate DWM-5A strain devoid of
pFL38MIP1. Haploid clones obtained will be named: Dmip1//
MIP1, Dmip1//mip1Y757C, Dmip1//mip1G224A respectively.
Strains carrying Dsml1 mutation were derived from strain
YG855, kindly obtained from Rodney Rothstein. This strain
was crossed with DWM-5A (Dmip1) thus obtaining the
diploid YO81 heterozygous at Dsml1 and Dmip1 loci. By spor-
ulation and tetrad analysis of this strain, we selected the spores
YO81-3A (Dsml1) and YO81-4B (Dmip1Dsml1). These clones
were then crossed to obtain the diploid DYYMIP1/DmipDsml1/
Dsml1, used as the host for wt MIP1 or mip1Y757C or mip1G224A
mutant alleles cloned in pFL38. For the construction of haploid
strains, DYY diploid strain, transformed with the pFL38MIP1
plasmid, was sporulated. By tetrad analysis, the haploid spore
DYY-4C Dmip1 Dsml1 carrying pFL38MIP1, therefore being
rþ, was selected. This strain was transformed by mip1G224A
mutant allele, cloned in the centromeric vector pFL39. By
plasmid shuffling in the presence of 5-fluoro orotic acid, it
was then possible to isolate the DYY-4C strain (Dmip1
Dsml1) carrying mipG224A allele and devoid of pFL38MIP1.
The same has been done also with MIP1 wt allele in order to
obtain strains transformed with the same plasmid pFL39 and
consequently carrying the same selectable marker, TRP1.
Construction of mutant alleles
The mip1G224A and mip1Y757C mutant alleles were produced by
site-directed mutagenesis, using the QuikChange Kit (STRA-
TAGENE). The template DNA was the wt MIP1 cloned in
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pUC19 vector. To obtain this construction, we PCR-amplified a
DNA fragment of 5110 bp, containing the ORF and the 5’ and 3’
flanking regions (851 and 441 bp, respectively), using genomic
DNA of strain W303-1B as template and the forward primer
MIP1C (containing a SacI site at the 5’ end) and the reverse
primer MIP1E (containing a SalI site at the 5’ end).
The list of base changes, and corresponding modified
primers used to generate mutated vectors, is reported in
Table 4. In order to maximize the expression of these variants,
the preferred yeast codons (42) were used in the oligonucleo-
tide sequences used for mutagenesis: GCT for Alanine and
TGT for Cysteine. Mutagenized inserts for each different con-
struct were sequence-verified on both strands. The sequences
of the oligonucleotide primers used for cloning and sequen-
cing MIP1 are also listed in Table 3.
Plasmids
MIP1 gene and mutant alleles were cloned in both the centro-
meric vectors pFL38 and pFL39 (43) at SacI and SalI sites.
These vectors carry URA3 and TRP1 markers, respectively.
RNR1 gene, cloned in the multicopy vector pRS425 (plasmid
pWJ841), was kindly obtained from Rodney Rothstein.
Mitochondrial DNA mutation frequency
Analysis of petite frequencies. Diploid and haploid strains
transformed with wt or mutated mip1 alleles were pregrown
overnight in YNB medium supplemented with 2% ethanol
and then inoculated in the same medium supplemented with
2% glucose. After 15 generations of growth at 368C, cells
were plated on YNB agar plates supplemented with 2%
ethanol and 0.25% glucose at a dilution that gave approxi-
mately 200 cells/plate. Petite frequencies were defined as
the percentage of colonies showing the petite phenotype
after a 5 day incubation at 288C.
To test the effect of dihydrolipoic acid, cells were grown in
YNB medium supplemented with 2% glucose in the presence
or in the absence of 30 mM dihydrolipoic acid (SIGMA) for 15
generations at 288C. These experiments were performed at
288C because lipoic acid at 378C determined high level of
cells lethality.
Evaluation of the nature of petite clones
In order to evaluate the nature of the petite mutants produced
by pathologic mutations, petite clones were crossed with mit2
strains harbouring point mutations in genes encoding respirat-
ory proteins. The four mit2 mutations used for this analysis
map in the first and in the sixth exons of cob gene, in the
cox2 gene and in the cox3 gene, respectively. This choice
was based on the observation that in the petite r2 mutants,
the fragments that are most frequently retained encompass
cytochrome b, cox2 and cox3 genes (44,45). The petite
clones unable to complement any of the mit2 mutants could
be either r0 (no mtDNA) or r2 carrying rearranged mtDNA
Table 3. List of yeast strains
Haploid strains Genotype Origin
W303-1B Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 Thomas and Rothstein (41)
W303-1A Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 Thomas and Rothstein (41)
OF1 Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR mip1:KanR derived from W303-1B
DWM-5A Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR Sporulation of DWM diploid strain
YG855 Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 sml1::HIS3
adh4::URA3
Rodney Rothstein
YO81-4B Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR
sml1::HIS3
Sporulation of YO81 diploid strain
YO81-3A Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 sml1::HIS3 Sporulation of YO81 diploid strain
YO81-5D Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 sml1::HIS3 Sporulation of YO81 diploid strain
DYY-4C Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR
sml1::HIS3
Sporulation of DYY diploid strain
M9-94-4B Mata ade1cox2 Franc¸oise Foury
M7-40-5B Mata ade1cob Franc¸oise Foury
M17-162-4D Mata ade1cob Franc¸oise Foury
M9-3-5B Mata ade1cox3 Franc¸oise Foury
M9-94/A1 Mata met cox2 Franc¸oise Foury
M9-3/A3 Mata met cox3 Franc¸oise Foury
M7-40/A1 Mata met cob Franc¸oise Foury
M17-162 Mata met cob Franc¸oise Foury
Diploid strains Genotype Cross
DWW Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100/ W303-1B  W303-1A
Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100
DWM Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100/ W303-1A  OF1
Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR
Y081 Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 sml1::HIS3
adh4::URA3/
YG855  OF1
Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR
DYY Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 sml1::HIS3/ YO81-3A  YO81-4B
Mata ade2-1 leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100 mip1::KanR
sml1::HIS3
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molecules which lack the three mutant genes. To distinguish
between these two possibilities, we evaluated the presence/
absence of mtDNA in a set of these clones by Southern analy-
sis. Mitochondrial DNA was extracted by rapid mitochondrial
preparation (46) from clones unable to complement any of the
mit2, grown in YNB supplemented with 2% glucose. Aliquots
of 1 mg of DNA were digested with EcoRV (Amersham).
Southern-blot analysis was carried out as previously described
(47). mtDNAs extracted from three rþ, three r2 and from
three r0 independent strains were also hybridized as a
control. Hybridization was performed by standard methods,
with a 50-[g-32P]ATP end-labelled yeast mtDNA-specific
sequence repeat (50-CTCCTTTCGGGGTTCCGGCTCCCG
TGGCCGGGCCCCGG-30) as a probe. Among the 25 putative
ro clones that were analysed with this method, no mtDNA was
observed in all but two clones, in which the mtDNA was likely
not to encompass any of the mit2 mutations (Fig. 3). These
results indicate that the absence of mit2 complementation is
a good indicator of a r0 condition.
Erythromycin resistance assays
Fifteen independent colonies from each strain were inoculated
in separate 10 ml cultures of YNB þ glucose and allowed to
reach the stationary phase. After 24 h, a small sample was
removed to determine the total number of respiration-
competent cells by plating onto YP supplemented with 2%
ethanol. The remainder of each culture was plated onto solid
N1 medium containing 4 mg/ml erythromycin (SIGMA) and
grown at 288C for 8 days until drug-resistant colonies
formed. The experiment was carried out in duplicate. The
mutation frequency was calculated as number of EryR colo-
nies/total number of colonies.
Miscellaneous
Transformation of yeast strain was obtained by the lithium
chloride method (48). Restriction enzyme digestions, E. coli
transformation and plasmid extractions were performed
using standard methods (47). Cytochrome spectra and respir-
ation were determined as described previously (10).
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